Glomcon is a resource for the kidney community to exchange ideas, learn, educate, and collaborate on projects. Membership via https://xitter.gq/t.co/xPsKBuWGcw
Joined May 2016
- Tweets9.3K
- Following932
- Followers16.3K
- Likes11.1K
Pinned Tweet
🚨 NOW OPEN: Pre-Application for Rare Kidney Disease/Glomerular Disease Centers of Excellence! 🚨
Join exceptional institutions, clinics, and healthcare organizations to become designated Centers of Excellence.
🎯 What you'll gain:
✅ Access to premier fellowship programs
✅ Secure database platform for operational and research registry
✅ Exclusive director network meetings
✅ Free conference registration + educational resources
✅ Clinical trial support services
✅ Population health dashboards
🏥 Perfect for:
• Academic medical centers
• Nephrology Clinics
• Healthcare institutions serving rare kidney disease populations
📅 Timeline: Pre-applications open NOW | Framework release Fall 2025
Ready to elevate your rare kidney disease program? Apply today! 👇
ikgplk7aacm.typeform.com/to/…
#RareKidneyDisease #GlomerularDisease #CentersOfExcellence #Nephrology #PatientCare
glomcon retweeted
Complete summary and more of IgA nephropathy using mass spectrometry.
1. Majority of IgA is IgA1.
2. Smaller amounts of IgA2 are also present.
3. Both IgA1 and IgA2 colocalize with IgG, showing that the deposits are composed of IgA1/IgG and IgA2/IgG.
4. Dominant IgG subclass is IgG1.
5. J chain that binds monomers of IgA into dimers is present in majority of cases, indicating that the IgA is mucosal derived (as circulating IgA is monomer and doesn’t have J chain)
6. Absence of PIGR indicates that IgA is not derived from secretions such as saliva, tears, etc. PIGR is a peptide in IgA (present in secretions), that prevent the breakdown of IgA by bacteria.
Taken together: IgA immune complexes in IgA nephropathy are made up of antigenic (galactose-deficient) mucosal-derived IgA and IgG.
7. Complement: Large amounts of C3 and C9 indicating alternative and terminal pathways of complement activation.
8. Minimal classical/no lectin pathway proteins.
9. Some correlation with MESTC score but bottom line= all IgA nephropathy shows lots of C3 and C9.
10. Abundant CFHR5 indicating that there is breakdown of C3 into inactive C3=iC3b.
11. Complement is a major player in the inflammatory process in IgA nephropathy.
kidney-international.org/art…
glomcon retweeted
Always a pleasure to see the @GlomCon family!
It’s amazing to see how much you’ve accomplished and how far GlomCon has come! ✨
#KidneyWk #kidneyweek2026 #Denver
glomcon retweeted
How low is low enough? New research explores the relationship between proteinuria levels and long-term kidney survival in immunoglobulin A nephropathy (IgAN), highlighting the importance of even very low proteinuria levels.
📅 Published October 8, 2026
🔗 Read the abstract: bit.ly/4hUzRjf
#GlomCon #Nephrology #KidneyResearch #RareKidneyDiseases #IgAN
How low is low enough? New research explores the relationship between proteinuria levels and long-term kidney survival in immunoglobulin A nephropathy (IgAN), highlighting the importance of even very low proteinuria levels.
📅 Published October 8, 2026
🔗 Read the abstract: bit.ly/4hUzRjf
#GlomCon #Nephrology #KidneyResearch #RareKidneyDiseases #IgAN
glomcon retweeted
Our first Editorial Board meeting happened yesterday evening- small group, but fruitful discussions! @GlomCon Photo with @wisit661 and @poyanmehr
Running a clinical trial is one thing. Running a trials program that pays for itself is another.
The new GlomCon Trialist Training Program teaches the operational side: Budget negotiation, staffing, regulatory compliance, sponsor relations. For academic centers and private practices alike. Free for GlomCon Rare Kidney Disease Network members.
Applications open on November 23, 2026.
Learn more at glomcon.org
#ClinicalTrials #Nephrology #RareDisease #GlomCon
The Kidney Pathology Certificate Program returns for its 2027 cohort.
Twelve months, six modules, from biopsy basics to allograft pathology: Live case webinars led by renal pathologists and nephrologists, pre-recorded lectures, and a certificate upon completion of program.
Directed by Vanesa Bijol, MD and Ibrahim Batal, MD.
Applications open on October 26, 2026.
Learn more at glomcon.org
#RenalPathology #Nephrology #Nephropathology #GlomCon
New for 2027: the GlomCon Transplant Scholars Program.
A 10-Month online program dedicated to advancing education in kidney transplantation: From candidate evaluation to post-transplant management, including pathology, protocols, complications, and living donor assessment.
Directed by Nay Seif, MD, MS, and Anshul Bhalla, MD. Built for fellows and practicing nephrologists.
Applications open November 9, 2026.
Learn more at glomcon.org
#Nephrology #KidneyTransplant #NephTwitter #GlomCon
glomcon retweeted
Segmental staining of glomeruli in NELL-1 Ag related membranous nephropathy
IF may be a clue to directing Ag-specific staining
@AnilaKurien @GlomCon
glomcon retweeted
Thank you to everyone who's already applied, we've been so inspired by your applications! 💛 If you're still thinking about it, we'd love to hear from you too. Applications close Oct 31, and we won't be able to extend the deadline, so be sure to get yours in. 🔥
#Undergraduates @GlomCon #NewGen #Education
Applications are now open for the GlomCon Undergraduate Mentorship Program! Connect with experienced physicians and researchers, gain real-world insight into clinical care and research, and build connections through GlomCon’s global network.
📅 Application deadline: October 31, 2026
🔗 Apply now: glomcon.org/undergraduate-me…
#GlomConFoundation #Nephrology #Mentorship #FuturePhysicians #KidneyDisease #KidneyEducation
glomcon retweeted
🎉 Our paper "Delphi Consensus Framework for Glomerular Disease Centers of Excellence" is out in @KIReports @GlomCon
sciencedirect.com/science/ar…
Centers of Excellence: Two new publications. One shared vision. GlomCon × ISGD!
Two consensus papers in Kidney International and Kidney International Reports mark an important step toward unifying glomerular disease care, research, education, and global access.
A unified global certification program is in development. More soon!
Read the papers here:
sciencedirect.com/science/ar…
sciencedirect.com/science/ar…
glomcon retweeted
Reinforcing more stringent proteinuria targets in IgA nephropathy; and especially simulation that the lower the better - we will need to re-tell this story (probably) with APRIL/BAFF inhibitors
Just published in #RKD @GlomCon
link.springer.com/article/10…
Join GlomCon this Sunday for the next GlomCon Sunday Seminar.
APOL1 Kidney Disease:
New Insights into Mechanisms, Pathology, and Therapeutic Opportunities
Presented by Sethu Madhavan, MD
Sunday, October 18, 2026 8:00AM PDT
Zoom ID: 81743744653
Passcode: 202122
Register to join live: glomcon.org
#kidneydisease #kidneyhealth #nephrology #kidneyeducation #kidneyresearch
glomcon retweeted
Another morning☀️ of insightful learning🤓 during the second part of Meta-Analysis session from our All-star🌟faculty Dr. Roddick @ajroddick and Dr. Herrington @willkidney at #RADIANT @GlomCon
glomcon retweeted
Now off to April/BAFF targeting therapies in IgAN by Dr. Ali Mehdi @CleClinicKidney @GlomCon @glomconarabia
glomcon retweeted
A great discussion with Dr. Ali Mehdi from @CleClinicKidney on the evolving IgA nephropathy treatment landscape.
Despite the advances, many questions remain! @glomconarabia @GlomCon
glomcon retweeted
𝗧𝗢𝗗𝗔𝗬: @GlomCon-ISN Webinar: Lysosomal storage-independent mechanism in Fabry disease, associated with milder course of renal disease.
Sunday, 11 October, 17:00 CEST
glomcon.zoom.us/
Use Meeting ID: 817 4374 4653
Passcode: 202122
glomcon retweeted
Time-averaged hematuria (serial measurements) predicts risk of kidney failure. Just published in #RKD; however, TA-proteinuria ≥ 0.5 g/day outperforms persistent hematuria!
link.springer.com/article/10…
Submit your research to #RKD! @GlomCon
glomcon retweeted
Each Fabry patient is different and screening is not making a diagnosis, so AGALopathy helps to understand the pathogenesis of Fabry disease. Wonderful talk by Dr Eva Hensova, Dr Jakub Sikora and Dr Gabriela Dostálová @ISNkidneycare @GlomCon
